• We provide care and education for diabetes patients, their families, and the general public.

• Our services cover type 1, type 2, gestational diabetes, and related complications.

Our diabetes care team, including endocrinologists, specialist nurses, dietitians, and pharmacists, provides personalized, integrated care. Using digital technology and remote glucose monitoring, we create tailored glucose control plans to improve accuracy, stability, and self-management. Services include diagnosis, screening, case management, treatment adjustment, long-term follow-up, education, and real-time consultation. Regular complication screenings are performed, with AI-assisted risk analysis and timely specialist referrals. Continuous resource integration and workflow optimization ensure high-quality, internationally standard diabetes care.

• GDM AI Platform: Innovative Learning and Care.

• OpenAI Translation: Promoting Health Equity.

• AI Remote Monitoring: Smart Self-Management.

• Smart Handover: Enhancing Timely and Continuous Care.

• One-Stop Complication Management System.

• Integrated and Learning-Oriented Diabetes Care.

• Standardized Nursing Assessment Tools.

• Easy Teaching Box: Streamlined Processes and Consistent Instruction

• Case Management: 8,422 patients/year

• Remote Glucose Monitoring: 291 patients/year

• One-Stop Screening: 11,269 visits/year

• Continuous Glucose Monitoring: 341 sessions/year

• 2024 Enrollment in Care Program: 79.98%

• 2024 HbA1c Testing Rate: 97.49%

• 2024 Fasting Lipid Profile Testing Rate: 92.12%

• 2024 Urine Microalbumin Testing Rate: 85.8%

• 2024 Fundus Examination Rate: 83.02%

• Hospital-wide Diabetes Patients with HbA1c <7.0%: 46.2%

• Hospital-wide Diabetes Patients with LDL <100 mg/dL: 66.2%

• Hospital-wide Diabetes Patients Meeting ABC Targets (BP <130/80 mmHg): 14.6%

• Hospital-wide Diabetes Patients with Urine Microalbumin <30%: 66.3%

• 2024 Rate of Inpatient Diabetes Patients with Blood Glucose ≤54 mg/dL: 0.26%

• 2024 Unplanned Readmission Rate within 14 Days after Discharge: 1.89%

• 2024 Rate of Inpatient Diabetes Patients with Blood Glucose >300 mg/dL: 5.05%

• 2024 Remote Glucose Monitoring Rate of Blood Glucose ≤54 mg/dL0.26%

• 2024 Inpatient Diabetes Mortality Rate (Including Discharge Against Medical Advice in Critical Condition): 2.65%

• 2024 Diabetes Education Center Satisfaction Rate: 98%

• 2024 Group Education Program Satisfaction Rate: 99%

• 2024 Patient Support Activities Satisfaction Rate: 95%

• 2024 Remote Glucose Care Patient Satisfaction Rate: 99%

• 2024 “Easy (Insulin) Teaching Box” Patient Satisfaction Rate: 98%

• 2024 “Easy (Insulin) Teaching Box” Nursing Staff Satisfaction Rate: 98%

• 2022 Remote glucose care for type 2 diabetes, using APP and cloud monitoring.

• 2022 SGLT-2 treatment efficacy analysis, applied to clinical drug selection and onitoring.

• 2023 SDM applied in gestational diabetes, enhancing patient decision-making and support.

• 2023 Post-vaccine autoimmune diabetes, tracking high-risk cases and adverse effects.

• 2024 ChatGPT in diabetes care, developing AI-assisted patient education tools.

• 2024 Remote glucose APP experience, optimizing platform and patient usage experience.

• 2025 Education skills improve injection accuracy, using tiered teaching by case managers.

• 2025 Precision health, contributing to Ministry of Education book on smart care strategies.

• Enhance domestic and international diabetes care quality and safety standards

• Establish standardized treatment and care process guidelines

• Strengthen blood glucose control, complication screening, and self-management

• Improve patient quality of life and satisfaction with care

• Support remote monitoring and smart care models

• Promote interdisciplinary team collaboration and knowledge sharing

• Facilitate evidence-based clinical decision-making

• Strengthen healthcare resource integration and sustainable care capacity